Study sheds light on the ability of CBD to reduce pain
It s been hailed as a wonder drug and it s certainly creating wonder profits. By some estimates, the Cannabidiol (or CBD) market could be worth $20 billion dollars by 2024. While users tout its effectiveness in pain relief, up until now there s been limited experimental human research on the actual effectiveness of the drug. However, a new study led by researchers at Syracuse University sheds light on the ability of CBD to reduce pain along with the impact that the so-called placebo effect may have on pain outcomes. For science and the public at large the question remained, is the pain relief that CBD users claim to experience due to pharmacological effects or placebo effects, asked Martin De Vita, a researcher in the psychology department at Syracuse University s College of Arts and Sciences. That s a fair question because we know that simply telling someone that a substance has the ability to relieve their pain can actuall
Many people who experience chronic pain report a degree of relief from using CBD, a non-psychoactive chemical found in cannabis. Though anecdotal reports often praise the substance for its pain relief effects, questions have remained over whether the drug is actually able to reduce pain itself. A new study from Syracuse University sought to answer the question, finding that the pain relief is real, but the user’s mind plays a role in the process.
CBD products come in many varieties, including oils, creams, candies, and vapes. Though purity may vary based on brand, these products are generally sold as THC-free, meaning they don’t give the user the stereotypical ‘high’ associated with cannabis. Medical CBD products are sold for multiple purported health benefits, one of which is pain relief.
E-Mail
IMAGE: Martin De Vita is a researcher in the psychology department at Syracuse University s College of Arts and Sciences and coauthor of the study. view more
Credit: Syracuse University
It s been hailed as a wonder drug and it s certainly creating wonder profits. By some estimates, the Cannabidiol (or CBD) market could be worth $20 billion dollars by 2024. While users tout its effectiveness in pain relief, up until now there s been limited experimental human research on the actual effectiveness of the drug. However, a new study led by researchers at Syracuse University sheds light on the ability of CBD to reduce pain along with the impact that the so-called placebo effect may have on pain outcomes.